BackBridgeBio Pharma Overview

BridgeBio Pharma Net Income

Profitability analysis for BBIO.

Quarterly Net Income

-$164.04M
2.02% YoY

As of Mar 2026

Annual Net Income (TTM)

-$725.93M
8.68% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...